Karolyn Morris

An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults

I T Magrath, Christopher Janus, BK Edwards et al. · Blood · 1984 · 251 citations · Full text

Medicine, Oncology, Pediatrics +11

Treatment-Related Adverse Events Predict Improved Clinical Outcome in NSCLC Patients on KEYNOTE-001 at a Single Center

Aaron Lisberg, D. Andrew Tucker, Jonathan W. Goldman et al. · Cancer Immunology Research · 2018 · 104 citations

Medicine, Oncology, Pharmacotherapy +16

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

Ryan C. Lynch, Ryan D. Cassaday, Stephen D. Smith et al. · The Lancet Haematology · 2021 · 56 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Polatuzumab vedotin with infusional chemotherapy for untreated aggressive B-cell non-Hodgkin lymphomas

Ryan C. Lynch, Christina Poh, Chaitra S. Ujjani et al. · Blood Advances · 2022 · 17 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Ibrutinib Monotherapy in Relapsed or Refractory, Transformed Diffuse Large B-cell Lymphoma

Solomon A. Graf, Ryan D. Cassaday, Karolyn Morris et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 13 citations · Full text

Medicine, Hematology, Oncology +10